Business Wire

The Estée Lauder Companies’ New Incubation Ventures and NYKAA Announce the BEAUTY&YOU India 2024 Winners

Share

The Estée Lauder Companies’ (NYSE: EL)(“ELC”) New Incubation Ventures (“NIV”) and NYKAA are pleased to announce the winners for BEAUTY&YOU India 2024. Created by NIV and launched in partnership with India’s leading beauty and lifestyle retailer NYKAA, BEAUTY&YOU India continues its mission to discover, spotlight, and propel the next generation of India-focused beauty brands. The 2024 program builds on the success of previous years with the theme of Supercharged Futures.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241028661723/en/

(From L to R): Piyush Jain, Dr. Prashant Agrawal, Falguni Nayar, Kritika Rathi, Vijay Sivaraju, Vaishnavi Maganti, Shana Randhava, Stéphane de La Faverie, William P. Lauder, Akshay Bawa, Alia Allana, Sumit Bhasin, Rosemin M. Opgenhaffen (Photo: Business Wire)

This year’s program saw more than 660 applicants from over 50 cities in the categories of skin care, makeup, hair care, fragrance, and storytelling. The top twelve finalists showcased concepts ranging from clinically advanced skin care to new breakthrough innovations in hair care and innovative storytelling platforms.

Finalists presented to this year’s esteemed jury of fourteen industry leaders and opinion-makers in a live pitch session at The Leela Palace in New Delhi. The four winners were announced the same evening at the finale event with special guests including William P. Lauder, Executive Chairman, ELC; Stéphane de La Faverie, Executive Group President, ELC; and Falguni Nayar, Founder, Managing Director and Chief Executive Officer, NYKAA; along with the jury – Shana Randhava, Senior Vice President, NIV, ELC; Rohan Vaziralli, General Manager, ELCA Cosmetics Private Limited; Tarun Tahiliani, Founder and Director, Tarun Tahiliani; Anaita Shroff Adajania, Stylist, Creative Director & Founder, Style Cell; Deepica Mutyala, CEO & Founder, Live Tinted; Shruti Chandra, Vice President, Invest India and Vice Chair, Women Empowerment, Europe India Council for Business and Industry (EICBI); Gianandrea Ferrari, CEO-Europe, Middle East & India, Intercos; Jaffrey Zaman, Managing Director, Intercos India Private Limited; among others.

“The winners of BEAUTY&YOU 2024 represent a diverse blend of creative founders and breakthrough innovation,” said Shana Randhava, Senior Vice President, NIV, ELC. “Their ideas and vision truly exemplified innovation, creativity, and entrepreneurial spirit, representative of beauty’s future. For the third year in a row, we witnessed some extraordinary concepts and the winners stand out as pioneers poised to make a significant impact – each bringing a unique perspective to India’s dynamic beauty landscape. We look forward to offering mentorship and support to the winners as they expand their visions, seeking a wider audience both in India and around the world.”

“As ELC’s lead partner for BEAUTY&YOU since its inception, NYKAA is deeply committed to nurturing the next generation of talent within the beauty industry,” said Anchit Nayar, Executive Director & CEO, NYKAA Beauty. “This year’s BEAUTY&YOU award winners represent the consumer-centric thinking in India, and we are proud to support these founders as they build high-quality brands for the Indian market. At NYKAA, nurturing the next generation of beauty entrepreneurs is core to our mission of making beauty accessible to all. We are proud to partner with The Estée Lauder Companies in this shared vision, as we work together to empower emerging talent and shape the future of beauty in India.”

2024 BEAUTY&YOU India Winners

GROW (In-Market Companies)

SkinInspired
Piyush Jain, Founder & CEO
Dr Prashant Agrawal, Founder & CPO
SkinInspired is a science-backed skin care company that uses multi-active ingredients that deliver results and innovative packaging that makes for a seamless user experience.
Instagram: @skininspired.in

IMAGINE (Pre-Market Concepts)

Not Just Vanilla
Akshay Bawa, Founder and CEO
Kritika Rathi, Founder and CMO
Not Just Vanilla redefines body care with targeted, results-driven solutions for overlooked areas, empowering consumers to feel confident and embrace self-love every day.
Instagram: @notjustvanilla.co

Amright
Vaishnavi Maganti, Founder
Vijay Sivaraju, Co-Founder
Amright combines clinically proven Swiss ingredients with genetic research on hair to promote female hair regrowth, offering custom solutions to fullness.
Instagram: @amrightindia

CREATE (Creative Storytellers)

Journey of Objects
Alia Allana, Founder & Journalist
Seamlessly blending reportage and retail, Journey of Objects is an e-commerce marketplace that helps embrace sustainability and preserve the cultural diversity of India through industry research and thoughtful product curation.
Instagram: @journeyofobjects

About BEAUTY&YOU India
Since its inception in 2022, BEAUTY&YOU aims to help founders, innovators and creators grow their businesses holistically by identifying brand goals, achieving scale ambitions and curating product portfolios that speak to a new generation of Indian consumers.

About The Estée Lauder Companies’ New Incubation Ventures
New Incubation Ventures (“NIV”) is the strategic early-stage investment and incubation arm for The Estée Lauder Companies. NIV partners with forward-thinking founders and entrepreneurs to create, fund, and support the best-emerging beauty brands and new business models to shape the future of beauty and build an actionable pipeline of diversified brands and new engines of growth for the ELC portfolio.

About The Estée Lauder Companies Inc.
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.

About NYKAA
Born out of a desire to make beauty a mainstream choice, NYKAA began in 2012 as a digitally native, consumer-tech company. Through founder Falguni Nayar’s vision to bring inspiration and joy to people everywhere, it tapped into an underserved beauty retail market, disrupting the ecosystem and putting India in the global spotlight. Today, NYKAA has expanded its offerings to include lifestyle and B2B by introducing online platforms NYKAA Fashion, NYKAA Man and Superstore.

Over the years, NYKAA has steadily captured the hearts of Indian consumers, ushering visits to its online and 175 offline destinations and building loyal communities through engaging and educational content. NYKAA continues to build its house of brands with a sharp focus on innovation and consumer delight. Beauty brands such as Kay Beauty, NYKAA Naturals, NYKAA Cosmetics and Wanderlust along with fashion brands such as Nykd, Gajra Gang, Likha, RSVP and Pipa Bella have become household names as they consistently deliver inspiration and high-performing products to the consumers.

NYKAA’s unwavering commitment to authenticity and putting the customer at the heart of everything that they do has made it the retailer of choice for international brands entering India. Its Global Store, a gateway into the world of coveted international brands, leverages the company’s proven supply chain and marketing capabilities to offer a truly seamless shopping experience.

Website:beautyandyouawards.com
Instagram:@beautyandyouawards

ELC-C

View source version on businesswire.com: https://www.businesswire.com/news/home/20241028661723/en/

Contacts

Media Relations:
Jill Marvin
jimarvin@estee.com

Investor Relations:
Rainey Mancini
rmancini@estee.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Nemluvio ® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis13.12.2024 23:09:00 CET | Press Release

Galderma (SWX:GALD) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nemluvio® (nemolizumab) for the treatment of patients 12 years and older with moderate-to-severe atopic dermatitis, in combination with topical corticosteroids (TCS) and/or calcineurin inhibitors (TCI) when the disease is not adequately controlled with topical prescription therapies. This follows the recent U.S. FDA approval of Nemluvio for subcutaneous injection for the treatment of adults with prurigo nodularis in August 2024.12 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241213562840/en/ Atopic dermatitis affects more than 230 million people worldwide, impacting approximately 7% of people in the U.S.2-4 Often reported as one of patients’ most problematic symptoms, 87% of people with atopic dermatitis say they are seeking freedom from itch, with speed of itch relief therefore also prioritized by both patient

Experian’s 2024 Global Identity & Fraud Report Spotlights Huge Growth in Highly Personalized GenAI-Driven Fraud Attacks13.12.2024 15:00:00 CET | Press Release

Today, Experian announced its 2024 Global Identity & Fraud Report that provides a comprehensive view of the consumer and business response to the latest fraud patterns and fraud‑mitigation strategies in the worldwide financial services sector. The report offers combined insights from more than 1,000 businesses and fraud leaders globally, as well as 4,000 consumers, focusing on fraud management and the digital experience. Among its key insights, the report casts a bright spotlight on three factors driving the fast-evolving fraud landscape: the huge growth in Generative Artificial Intelligence (GenAI) technologies, changing government regulations, and the push among businesses to provide consumers with secure and convenient digital experiences. In response to these factors, the report’s findings revealed that businesses intend to increase fraud budgets driven by investments in AI and machine learning technologies. “Unlike other issues facing financial services companies, fraud operates b

Capcom Announces Onimusha Way of the Sword , Marking the First New Title in the Series in Over 20 Years! Work on an Okami Sequel Project Begins!13.12.2024 14:00:00 CET | Press Release

Capcom Co., Ltd. (TOKYO:9697) today announced that Onimusha Way of the Sword, the first new title in the Onimusha series in over 20 years, is scheduled to be released, while work on an Okami sequel project has also started. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241213232085/en/ Onimusha Way of the Sword (Graphic: Business Wire) The Onimusha series consists of swordplay action games where players assume the role of warriors with the superhuman powers of the Oni and fight against monsters bent on world domination. Onimusha Way of the Sword, scheduled to be released globally in 2026, is a Japanese-inspired dark fantasy game set at the beginning of the Edo period in Kyoto, which has been eerily transformed by clouds of Malice. In the game, the samurai protagonist is equipped with the Oni Gauntlet and engages in epic sword battles with the grotesque and otherworldly creatures known as Genma. Capcom hopes that players loo

BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell13.12.2024 13:51:00 CET | Press Release

BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and Cellistic, a leader in advanced iPS cell therapy manufacturing, today announced a process development and manufacturing agreement to advance BrightPath’s novel allogeneic CAR-T cell therapy platform, utilizing iPSC-derived NKT cells for clinical trials. The strategic collaboration includes the use of Cellistic's innovative 3D bioreactor-based manufacturing platform, Echo, to enable GMP-compliant, clinical-scale manufacturing of iPSC-derived BCMA-targeting CAR-NKT cells for Phase 1 multiple myeloma trial; establishing BrightPath as a first mover in this emerging field. “The use of NKT cells as effectors in allogeneic CAR-T therapy represents a promising strategy, offering not only direct cytotoxicity but also indirect anti-tumor activity through the priming of host CD8+ T cells—a mechanism expected to evade host immune rejection and to enhance the dur

CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union13.12.2024 07:00:00 CET | Press Release

Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting the marketing authorization of nemolizumab for the treatment of both atopic dermatitis and prurigo nodularis in the European Union (EU). The CHMP has recommended nemolizumab’s approval for subcutaneous use for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older who are candidates for systemic therapy, and for subcutaneous use for the treatment of adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy. This follows its approval for the treatment of adults with prurigo nodularis by the United States (U.S.) Food and Drug Administration (FDA) in August 2024.14 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241212936857/en/ Atopic dermatitis is a common, chronic, and flaring infl

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye